GI & Endoscopy

Medicare beneficiaries may engage with a multi-target stool DNA test better than a fecal immunochemical test, according to a study debuted digitally at Digestive Disease Week 2020.

Thompson Health Gastroenterology is relocating to a new outpatient clinic May 4, the Daily Messenger reports.

The American Gastroenterological Association released a guideline on the consultative management of COVID-19 patients.

CellMax Life released results from its U.S. study of the FirstSight blood test that revealed the test detected colorectal cancer with 100 percent sensitivity at 90 percent specificity.

Phoenix-based Arizona Digestive Health expects patient volumes in May will be just a fraction of what they were before the pandemic, gastroenterologist Paul Berggreen, MD, told Medscape Medical News.

RDD Pharma, Innovate Biopharmaceuticals and Naia Rare Diseases merged and formed 9 Meters Biopharma, which will develop treatments for orphan diseases and unmet needs in gastroenterology.

Here are the five most-read Becker's ASC Review articles for gastroenterologists the week of April 27-May 1:

A combination of liquid biopsy screening tests and conventional screening practices could present a more complete oncology picture, according to a study published in Science. 

Here are six updates from gastroenterology companies and practices from the past week:

Gastroenterology-focused group purchasing organization Gastrologix partnered with Clinical Research Strategy Group to facilitate discounted rates to CSRG's clinical trial management platform.